First Analysis invests in 4G Clinical

First Analysis has made an investment in Wellesley, Massachusetts-based 4G Clinical, a provider of randomization and trial supply management solutions for the life sciences industry.

ByIris Dorbian

29 January 2020•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Healthcare Briefs

First Analysis invests in 4G Clinical

First Analysis

Related articles